Vanguard’s 7.3% Cencora Stake Highlights Valuation Gap And Risks

Vanguard Capital Management has revealed a 7.3% stake in Cencora (NYSE:COR), held for investment purposes, classifying them as one of the largest institutional holders. Cencora is a key player in pharmaceutical distribution, offering investors exposure to healthcare demand without direct drug development risk. Despite this institutional interest, the stock trades significantly below analyst targets and an estimated fair value, while facing minor risks like high debt.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin